BPC-157, TB-500,Cartalax

BPC-157 / TB-500 / Cartalax Blend 48mg – Cellular & Connective Tissue Research Peptide Blend

BPC-157 / TB-500 / Cartalax Blend is a triple-peptide research formulation containing 12mg of BPC-157, 12mg of TB-500, and 24mg of Cartalax, for a total peptide content of 48mg per vial.

This formulation is intended for laboratory investigation of cellular signaling, connective tissue biology, extracellular matrix regulation, and peptide-mediated biological pathways.

BPC-157 is a synthetic research peptide studied in preclinical models for its interactions with pathways associated with cellular migration, angiogenic signaling, nitric oxide regulation, and tissue-response mechanisms.

TB-500 is a synthetic peptide associated with Thymosin Beta-4 research. It is investigated for its relationship with actin regulation, cytoskeletal organization, cellular migration, and tissue-remodeling pathways.

Cartalax (Ala-Glu-Asp / AED) is a synthetic tripeptide studied for its potential involvement in cartilage-associated cellular signaling, extracellular matrix biology, and gene-expression regulation. Research interest includes its interactions with connective tissue and age-associated cellular processes.

Together, these three compounds provide researchers with a multi-peptide formulation for investigating distinct biological signaling mechanisms within controlled laboratory environments. The combined formulation has not been established to produce synergistic effects.

Research Applications

Laboratory investigations may include:

* Connective tissue and cartilage-associated research

* Cellular migration and signaling pathways

* Extracellular matrix and collagen-related mechanisms

* Cytoskeletal organization and actin dynamics

* Gene-expression and cellular regulatory pathways

* Angiogenic and vascular signaling

* Cellular homeostasis and stress-response models

* Multi-peptide interaction studies

Blend Composition

* BPC-157: 12mg

* TB-500: 12mg

* Cartalax (AED): 24mg

* Total Peptide Content: 48mg

* Blend Ratio: 1:1:2

Product Information

Product Name: BPC-157 / TB-500 / Cartalax Blend

Strength: 48mg Total

Formulation: 12mg BPC-157 + 12mg TB-500 + 24mg Cartalax

Category: Cellular / Connective Tissue Research Peptide Blend

Form: Lyophilized research material

Use: Laboratory research and analytical applications

Why Researchers Study This Blend

The BPC-157 / TB-500 / Cartalax formulation brings together three research peptides associated with different aspects of cellular communication, structural biology, and connective tissue signaling.

While BPC-157 and TB-500 are primarily investigated in preclinical models involving cellular migration and tissue-response pathways, Cartalax provides an additional area of investigation involving cartilage-related biology and gene-regulatory mechanisms.

Research involving this specific three-peptide combination remains limited, and its combined biological activity, compatibility, and safety have not been clinically established.

Important Research Notice

FOR RESEARCH USE ONLY (RUO). NOT FOR HUMAN OR VETERINARY USE.

This product is supplied exclusively as a laboratory research material. It is not an approved drug, dietary supplement, cosmetic, or medical product and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

All products offered by Genora Peptides are intended solely for legitimate laboratory and analytical research conducted by qualified professionals.

Information provided is for scientific reference purposes only and should not be interpreted as medical advice, dosing guidance, or instructions for human administration.

⚠️ For Research Purposes Only: This product is intended for laboratory research use only. Not for human or animal consumption.